Advertisements


We are Sorry, This Page doesn't Exist


Eli Lilly cuts 2019 forecast on trial failure, Loxo deal

Eli Lilly and Co cut its 2019 profit forecast on Wednesday, hit by a recent trial failure of conditionally approved cancer treatment Lartruvo and costs related to its pending acquisition of Loxo Oncology......»»

Category: topSource: reutersFeb 6th, 2019

In major cell therapy manufacturing deal, UCSF, biotech tools leader Thermo Fisher go small to go big

The new cell therapy manufacturing facility, which will open early next year, will be able to deliver highly specialized cell therapies to patients in clinical trials at UCSF's women's, children's and cancer hospitals complex across Mariposa Street......»»

Category: topSource: bizjournalsMay 19th, 2021

Bristol Meyers Squibb pays $200M for Lexington biotech"s cancer antibody

Agenus Inc. has signed its largest licensing deal ever for a tumor-fighting antibody that is still in preclinical development......»»

Category: topSource: bizjournalsMay 18th, 2021

Fremont gaming hardware company Corsair is moving its headquarters to Milpitas after signing a 118,000-square-foot lease there

The maker of PC keyboards and mice for gamers announced the deal one day before reporting standout earnings......»»

Category: topSource: bizjournalsMay 4th, 2021

Cryptos: Trevor Lawrence, expected to be the No. 1 pick in the NFL draft, signs endorsement deal with crypto app Blockfolio

Lawrence accepted his signing bonus from this endorsement deal exclusively in crypto in a mix of bitcoin, ethereum and Solana......»»

Category: topSource: marketwatchApr 26th, 2021

Earl "E-40" Stevens on growing a "spirits empire" in a pandemic, investing early in Clubhouse, and how a Verzuz appearance propelled his business

Earl "E-40" Stevens spoke to Insider in a wide-ranging interview tied to the signing of a national distribution deal for his spirits business. Earl "E-40" Stevens. Phil Emerson Hip-hop icon and en.....»»

Category: dealsSource: nytApr 23rd, 2021

Starz subscribers can save 10% right now by signing up for 3 months of the service

You can get three months of Starz for just $24. Here's how to get the deal with a free trial s.....»»

Category: personnelSource: nytApr 7th, 2021

Biden"s stimulus looks bigger than the New Deal, economics professor says

"We've never done this," professor Leonard Burman said of Biden's spending, saying that FDR's New Deal spending was "way too small" for that crisis. FDR in the White House in 1933; Biden signing the American Rescue Plan in 2021. AP Photo; A.....»»

Category: dealsSource: nytMar 30th, 2021

Sigma Labs soars 200% after signing deal with Lockheed Martin for the software company"s PrintRite3D product

PrintRite3D is an in-process quality assurance system that use.....»»

Category: worldSource: nytMar 15th, 2021

Global stocks edge lower on fresh concerns of COVID-19 cases despite Biden signing the $1.9 trillion stimulus deal

France and Germany are resisting imposing lockdowns even as they see stubbornly high infection rates. Michael Nagle/Xinhua/Getty Images European and US stocks edged lower on .....»»

Category: topSource: businessinsiderMar 12th, 2021

Amgen to buy Five Prime Therapeutics in a deal valued at $1.9 billion to boost cancer treatment portfolio

Amgen Inc. announced Thursday an agreement to buy biotechnology company Five Prime Therapeutics Inc......»»

Category: topSource: marketwatchMar 4th, 2021

The Wall Street Journal: Amazon near NFL deal to stream more games exclusively on Prime Video

The National Football League is on the verge of signing new rights deals with media partners that could see Amazon.com Inc. carry many games exclusively and TV networks pay as much as double their current rate, people familiar with the matter said......»»

Category: topSource: marketwatchMar 3rd, 2021

Spinout from Nobel-winning Berkeley lab cuts cancer cell therapy deal with drug giant AbbVie

Caribou Biosciences Inc. — one of the first companies to spin Nobel Prize-winning UC Berkeley professor Jennifer Doudna's CRISPR genome-editing technology out of her lab — inked a deal with drug giant AbbVie Inc. to help develop an off-the-shel.....»»

Category: topSource: bizjournalsMar 3rd, 2021

Cannabis Watch: Tilray stock loses steam as analysts say company not compelling as stand-alone business, look to Aphria deal

Tilray Inc. shares fell on Thursday, as analysts weighed in on the company's latest quarterly earnings with most looking ahead to the company's pending merger with Aphria Inc., saying Tilray looks less compelling on its own......»»

Category: topSource: marketwatchFeb 20th, 2021

The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16) read more.....»»

Category: blogSource: benzingaFeb 17th, 2021

How this cancer-fighting company from China quietly landed as the Bay Area"s latest biotech IPO

The company's co-founder, chairman and CEO is based in San Francisco, and it recently cut a deal with an East Bay biotech company......»»

Category: topSource: bizjournalsFeb 9th, 2021

Lilly signs cancer drug deal worth up to $1.6 billion

S.....»»

Category: topSource: marketwatchJan 20th, 2021

UPDATE: Myovant shares soar 20% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion

Shares of Myovant Sciences soared 20% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant wi.....»»

Category: topSource: marketwatchDec 28th, 2020

Pfizer and Myovant to jointly develop women"s cancer treatment in deal worth up to $4.2 bln

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchDec 28th, 2020

Myovant shares soar 16% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion

Shares of Myovant Sciences soared 16% in premarket trade Monday, after its parent Sumitovant Biopharma said .....»»

Category: topSource: marketwatchDec 28th, 2020